Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.077 | 0.7 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.076 | 0.7 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |